eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine.
Many factors contribute to risk of a disease. Some of these factors are internal, like genetics, and others are external, like where someone lives. Over the last several years researchers have discovered that in addition to one gene being associated with a given disease (monogenic factors), many genes across your genome can contribute to the development of a disease (polygenic factors). To learn more about elements that contribute to risk a disease, click here.
NIH Opportunities: Information on Loan Repayment and Mosiac Program
August 8, 2021 2:39 PM
eMERGE Network: Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals (JAMA)
August 8, 2021 8:43 PM
RFI on Developing Consent Language for Future Use of Data and Biospecimens
July 7, 2021 3:27 PM
AIM-AHEAD Research Opportunity Announced
July 7, 2021 4:03 PM
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
July 7, 2021 4:32 PM
RFI: Broaden the Benefits of AI/ML Technologies to Reduce Health Disparities and Inequities and Enhance the Diversity of the AI/ML Workforce
June 6, 2021 7:53 PM
Wynn J, Milo Rasouly H, Vasquez-Loarte T, Saami AM, Holm IA, et al. Do research participants share genomic screening results with family members? Journal of genetic counseling. 2021 Oct 19;.
Zanussi JT, Zhao J, Dorn CA, Liu G, Kawai VK. Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach. Clinical pharmacology and therapeutics. 2021 Oct 8;.
Dickson AL, Daniel LL, Zanussi J, Dale Plummer W, Chung CP, et al. TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results. Clinical pharmacology and therapeutics. 2021 Sep 28;.